Advertisement

Topics

UGenRA - Genitourinary cancer array - Biotech, Pharma and Life Science Channel

22:36 EDT 26th July 2017 | BioPortfolio

UGenRA is a CGI custom-designed oligonucleotide array designed to detect gains and losses of genomic material in endometrial, ovarian, and cervical cancers. Endometrial hyperplasia is a precursor lesion of endometriod endometrial carcinoma (EEC) and since about 50% of women with atypical hyperplasia also have concurrent EEC, it is important to identify those precursor lesions more likely to progress to and those with frank cancer. UGenRATM offers the opportunity to identify such specimens and potentially guide clinical management. Another potential application is to stratify those tumors likely to recur, permitting the identification of patients most likely to benefit from adjuvant therapy. Risk-stratification of stage III/IV ovarian cancer patients after cytoreductive surgery for front-line platinum taxane-based chemotherapy is a potential application for UGenRATM, and the design currently contains the sites of genomic gain/loss with such prognostic value. For any of the three cancers, genomic gain/loss associated with response to particular therapies can be assessed using UGenRATM, especially with the need of only small amounts of starting material and the ability to perform UGenRATM on FFPE specimens.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/  UGenRA is a Registered Trademark of CGI

PubMed Articles [17049 Associated PubMed Articles listed on BioPortfolio]

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

A patient's medical history and familial cancer history are important information for assessing the risk of hereditary cancer. We have generated a self-administered questionnaire for patients with gyn...

Anal metastasis of rectal cancer-adenocarcinoma of squamous cells: a case report and literature review.

Anal metastasis of colorectal cancer is very rare and is usually associated with a history of anal disease, including anal fistula, fissure, hemorrhoidectomy, and anastomotic injury. We report a case ...

Transcatheter arterial embolization for intercostal arterio-esophageal fistula in esophageal cancer.

While esophageal fistula formation in the adjacent organs is associated with high rates of morbidity and mortality, the management of non-aortic arterio-esophageal fistula has not been frequently repo...

Should the FDA Ban Cigarette Filter Ventilation?

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

The 2014 Surgeon General's Report on smoking and health concluded that changing cigarette designs have caused an increase in lung adenocarcinomas, implicating cigarette filter ventilation that lowers ...

A fascia lata free flap in pelvic exenteration for Fournier gangrene due to advanced rectal cancer: a case report.

Fournier gangrene due to advanced rectal cancer is a rapidly progressive gangrene of the perineum and buttocks. Emergency surgical debridement of necrotic tissue is crucial, and secondary surgery to r...

Economic burden of cancer among patients with surgical resections of the lung, rectum, liver and uterus: results from a US hospital database claims analysis.

To determine hospital resource utilization, associated costs and the risk of complications during hospitalization for four types of surgical resections and to estimate the incremental burden among pat...

A CZT-based blood counter for quantitative molecular imaging.

Robust quantitative analysis in positron emission tomography (PET) and in single-photon emission computed tomography (SPECT) typically requires the time-activity curve as an input function for the pha...

Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.

Molecular breast imaging (MBI) performed with (99m)Tc sestamibi has been shown to be a valuable technique for the detection of breast cancer. Alternative radiotracers such as (99m)Tc maraciclatide may...

Demonstration of Logic Operations in High-Performance RRAM Crossbar Array Fabricated by Atomic Layer Deposition Technique.

In this paper, resistive random access memory (RRAM)-based crossbar arrays with the cell structure of Pt/[AlO y /HfO x ] m /TiN were fabricated by using atomic layer deposition (ALD) technique. The RR...

News Articles [13904 Associated News Articles listed on BioPortfolio]

Giant radio telescope scaled back to contain costs

Crowding antennas closer together may affect the Square Kilometre Array's ability to observe the early Universe.

Neuromorphic computing with nanoscale spintronic oscillators

Neurons in the brain behave as nonlinear oscillators, which develop rhythmic activity and interact to process information. Taking inspiration from this behaviour to realize high-density, low-power neu...

Civitas Solutions, Inc. to Present at Canaccord Genuity Growth Conference in August

Civitas Solutions, Inc. (NYSE: CIVI) today announced that its management will present at the Canaccord Genuity 2017 Growth Conference in Boston. Civitas Solutions’ presentation ...

Civitas Solutions, Inc. Announces Schedule for Release of Fiscal 2017 Third Quarter Operating Results and Conference Call

Civitas Solutions, Inc. (NYSE: CIVI) announced today that it plans to release its 2017 third quarter operating results on Wednesday, August 9, 2017 after market close. The announc...

Do All Patients with Rectal Cancer Need Surgery? Gastro and Endo News Report

(MedPage Today) -- Also, cannabinoid hyperemesis syndrome on the rise

Adaptive’s ImmunoSEQ Platform to be Used for Immunosequencing-Based Biomarker Discovery in NCI Trials

SEATTLE–(BUSINESS WIRE)–Adaptive Biotechnologies, a pioneer in combining next-generation sequencing and expert bioinformatics to profile T-cell and B-cell receptors (TCRs and BCRs) of the ...

STAT Plus: Strong growth in sales of colon cancer test dents the pessimism of Exact Sciences shorts

Exact Sciences, the maker of the Cologuard test for detecting colon cancer, spends a lot on marketing, but that's driving growth — and frustrating shorts.

Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell Therapeutics

Scientists in the U.S. have created genetically engineered mesenchymal stem cells (MSCs) that can recognise and target ‘stiff’ metastatic tumor tissue and deliver cancer-killing drugs directly to ...

UZ Leuven Orders Varian Halcyon Cancer Treatment System

PALO ALTO, Calif., July 26, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that the University Hospitals Leuven (UZ Leuven) in Belgium, have ordered the new Halcyon™ treatme...

Varian Installs Cyclotron at Georgia Proton Treatment Center

PALO ALTO, Calif., July 26, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) installed a Varian ProBeam® cyclotron at the Georgia Proton Treatment Center, LLC in Atlanta.  The cyclot...

Events [0 Results]

None

Companies [681 Associated Companies listed on BioPortfolio]

Rebound Therapeutics

Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgi...

Helix BioMedix, Inc

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our co...

Philogen

Philogen is a Swiss-Italian clinical-stage company engaged in the discovery and development of novel pharmaceutical and biopharmaceutical products. Philogen’s strategy is to ...

Veracyte, Inc.

Veracyte is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable...

Abzena plc and Telix Pharmaceuticals Limited

“Radio-immunoconjugates have tremendous potential as one of the most adaptable site specific, precision medicines and, in prostate cancer, PSMA is increasingly recognised as ...

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in...

Samumed, LLC

Based in San Diego, CA, Samumed (www.samumed.com) is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and in...

StemSynergy Therapeutics, Inc.

StemSynergy is a privately held biopharmaceutical company that focuses on the discovery and development of drugs targeting developmental pathways fundamental to cancer. For more i...

Lumicell, Inc.

Lumicell is a leader in the field of image-guided cancer surgery. The company is developing a revolutionary intraoperative imaging system that gives surgeons real-time visual feed...

Dendreon Pharmaceuticals LLC

Dendreon is a healthcare company whose mission is to transform lives through the discovery, development, commercialization and manufacturing of novel personalized immune-therapeut...

Clinical Trials [6138 Associated Clinical Trials listed on BioPortfolio]

Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

The multi-centered, cross-sectional investigations shall be conducted in this study with the objective of identifying the ownership ratio of gBRCAm on the newly diagnosed patients with epi...

Determinants of Preterm Birth in Boston Birth Cohort

Early life exposures may lead to adverse effects on health in later life. The Boston birth Cohort study is designed to study a broad array of early life factors and their effects on pregna...

A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance

This study is a clinical trial to determine whether a 12-week group therapy intervention for patients undergoing Active Surveillance for Prostate Cancer can relieve disease-related anxiety...

Superior Hypogastric Plexus Block Versus Pulsed Radiofrequency for Chronic Pelvic Cancer Pain

Cancer-related pain represents a major challenge for both clinicians and patients. This pain can be associated directly with the cancer or with certain treatments administered to the patie...

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

This is a Phase II study of pembrolizumab plus mifepristone in advanced breast cancer patients. The study will include a safety lead in of ten patients. Patients who are deemed eligible an...

Cranial Osteopathic Manipulative Medicine as an Adjunct Treatment for Concussion

Patients who have concussions exhibit an array of symptoms, also known as post-concussive symptoms, including headaches, feeling slowed down or foggy and difficulty with concentration. Thi...

Patient Navigation to Improve Patient-Centered Cancer Care

The MGH Cancer Center's patient navigation (PN) program, utilizes specially trained community-based personnel to improve cancer care in underserved communities by increasing cancer screeni...

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

In this study, PLD, an anthracycline encapsulated in stealth liposomes, which are believed to efficiently deliver the doxorubicin within the tumour mass with less toxicity compared with st...

Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle

At present, the evaluation criterion of endometrial receptivity is controversial. The development of a molecular diagnostic tool, the endometrial receptivity array (ERA) for diagnosis of e...

HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individua...

Videos

None available.

Medical and Biotech [MESH] Definitions

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.

A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

review and buy UGenRA - Genitourinary cancer array market research data and corporate reports here

Channels Quicklinks